Early in tumor development, circulating tumor cells (CTCs) detach from primary or metastatic lesions and are important ...
Columbia University scientists have engineered a microfluidic chip that sustains living glioblastoma tumor slices, enabling precise drug testing and high-resolution genomic analysis. By controlling ...
Combining microchip engineering techniques with cutting-edge gene profiling, scientists at Columbia University have developed ...
The organ-on-chip market offers opportunities driven by the demand for alternatives to animal testing, advances in ...
Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...
Global Point-of-Care Diagnostics Market Size Set to Reach USD 114.65 Billion by 2035 – SNS Insider
Advancements in biosensors, microfluidics, and AI-driven diagnostics accelerate adoption across hospitals and home care, with strong U.S. and Asia-Pacific growth momentum.Austin, United States, April ...
Objective: To evaluate the detection performance of microfluidic chip-based multiplex PCR technology for rapid detection of ...
The Human Vascular System Stretches Up to 100,000 Miles — Standard Imaging Captures Only a Fraction of It The Endothelial Glycocalyx: A Microscopic Lining That Helps Regulate How Blood Moves Through ...
Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results